<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 42 - THE PUBLIC HEALTH AND WELFARE</title></head><body>
<span style="font-weight:bold;font-size:12pt;">42 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2005 Edition</span><br/>
<span style="font-size:10pt">Title 42 - THE PUBLIC HEALTH AND WELFARE</span><br/>
<span style="font-size:10pt">CHAPTER 6A - PUBLIC HEALTH SERVICE</span><br/>
<span style="font-size:10pt">SUBCHAPTER III - NATIONAL RESEARCH INSTITUTES</span><br/>
<span style="font-size:10pt">Part C - Specific Provisions Respecting National Research Institutes</span><br/>
<span style="font-size:10pt">subpart 3 - national institute of diabetes and digestive and kidney diseases</span><br/>
<span style="font-size:10pt">Sec. 285c-3 - Interagency coordinating committees</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:42_285c-3  usckey:420000000028500000000000c00030000 currentthrough:20060102 documentPDFPage:474 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER III/Part C/subpart 3/Sec. 285c-3 -->
<!-- itemsortkey:420AARV -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER III-NATIONAL RESEARCH INSTITUTES!@!Part C-Specific Provisions Respecting National Research Institutes!@!subpart 3-national institute of diabetes and digestive and kidney diseases!@!Sec. 285c-3 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;285c&ndash;3. Interagency coordinating committees</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Establishment and purpose</h4>
<p class="statutory-body">For the purpose of&mdash;</p>
<p class="statutory-body-1em">(1) better coordination of the research activities of all the national research institutes relating to diabetes mellitus, digestive diseases, and kidney, urologic, and hematologic diseases; and</p>
<p class="statutory-body-1em">(2) coordinating those aspects of all Federal health programs and activities relating to such diseases to assure the adequacy and technical soundness of such programs and activities and to provide for the full communication and exchange of information necessary to maintain adequate coordination of such programs and activities;</p>
<br class="Q04" />
<p class="statutory-body-block">the Secretary shall establish a Diabetes Mellitus Interagency Coordinating Committee, a Digestive Diseases Interagency Coordinating Committee, and a Kidney, Urologic, and Hematologic Diseases Coordinating Committee (hereafter in this section individually referred to as a &ldquo;Committee&rdquo;).</p>
<h4 class="subsection-head">(b) Membership; chairman; meetings</h4>
<p class="statutory-body">Each Committee shall be composed of the Directors of each of the national research institutes and divisions involved in research with respect to the diseases for which the Committee is established, the Division Director of the Institute for the diseases for which the Committee is established, the Under Secretary for Health of the Department of Veterans Affairs, and the Assistant Secretary of Defense for Health Affairs <!-- PDFPage:475 -->(or the designees of such officers) and shall include representation from all other Federal departments and agencies whose programs involve health functions or responsibilities relevant to such diseases, as determined by the Secretary. Each Committee shall be chaired by the Director of NIH (or the designee of the Director). Each Committee shall meet at the call of the chairman, but not less often than four times a year.</p>
<h4 class="subsection-head">(c) Annual report</h4>
<p class="statutory-body">Each Committee shall prepare an annual report for&mdash;</p>
<p class="statutory-body-1em">(1) the Secretary;</p>
<p class="statutory-body-1em">(2) the Director of NIH; and</p>
<p class="statutory-body-1em">(3) the Advisory Board established under section 285c&ndash;4 of this title for the diseases for which the Committee was established,</p>
<br class="Q04" />
<p class="statutory-body-block">detailing the work of the Committee in carrying out paragraphs (1) and (2) of subsection (a) of this section in the fiscal year for which the report was prepared. Such report shall be submitted not later than 120 days after the end of each fiscal year.</p>
<h4 class="subsection-head">(d) Annual assessment on Federal pancreatic islet cell transplantation</h4>
<p class="statutory-body">In each annual report prepared by the Diabetes Mellitus Interagency Coordinating Committee pursuant to subsection (c) of this section, the Committee shall include an assessment of the Federal activities and programs related to pancreatic islet cell transplantation. Such assessment shall, at a minimum, address the following:</p>
<p class="statutory-body-1em">(1) The adequacy of Federal funding for taking advantage of scientific opportunities relating to pancreatic islet cell transplantation.</p>
<p class="statutory-body-1em">(2) Current policies and regulations affecting the supply of pancreata for islet cell transplantation.</p>
<p class="statutory-body-1em">(3) The effect of xenotransplantation on advancing pancreatic islet cell transplantation.</p>
<p class="statutory-body-1em">(4) The effect of United Network for Organ Sharing policies regarding pancreas retrieval and islet cell transplantation.</p>
<p class="statutory-body-1em">(5) The existing mechanisms to collect and coordinate outcomes data from existing islet cell transplantation trials.</p>
<p class="statutory-body-1em">(6) Implementation of multiagency clinical investigations of pancreatic islet cell transplantation.</p>
<p class="statutory-body-1em">(7) Recommendations for such legislation and administrative actions as the Committee considers appropriate to increase the supply of pancreata available for islet cell transplantation.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title IV, &sect;429, as added Pub. L. 99&ndash;158, &sect;2, Nov. 20, 1985, 99 Stat. 843; amended Pub. L. 100&ndash;527, &sect;10(4), Oct. 25, 1988, 102 Stat. 2641; Pub. L. 102&ndash;405, title III, &sect;302(e)(1), Oct. 9, 1992, 106 Stat. 1985; Pub. L. 108&ndash;362, &sect;3, Oct. 25, 2004, 118 Stat. 1703.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">2004&mdash;Subsec. (d). Pub. L. 108&ndash;362 added subsec. (d).</p>
<p class="note-body">1992&mdash;Subsec. (b). Pub. L. 102&ndash;405 substituted &ldquo;Under Secretary for Health of the Department of Veterans Affairs&rdquo; for &ldquo;Chief Medical Director of the Department of Veterans Affairs&rdquo;.</p>
<p class="note-body">1988&mdash;Subsec. (b). Pub. L. 100&ndash;527 substituted &ldquo;Chief Medical Director of the Department of Veterans Affairs&rdquo; for &ldquo;Chief Medical Director of the Veterans&rsquo; Administration&rdquo;.</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-amendment-note -->
<h4 class="note-head">Effective Date of 1988 Amendment</h4>
<p class="note-body">Amendment by Pub. L. 100&ndash;527 effective Mar. 15, 1989, see section 18(a) of Pub. L. 100&ndash;527, set out as a Department of Veterans Affairs Act note under section 301 of Title 38, Veterans&rsquo; Benefits.</p>
<!-- field-end:effectivedate-amendment-note -->
<!-- field-end:notes -->


</body></html>